These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16699664)

  • 21. Bilateral multifocal retinal pigment epithelium detachment and pachychoroidopathy.
    Nagesha CK; Megbelayin EO
    Indian J Ophthalmol; 2018 Apr; 66(4):570-571. PubMed ID: 29582823
    [No Abstract]   [Full Text] [Related]  

  • 22. Characteristics of acute central serous chorioretinopathy on optical coherence tomography - a retrospective study.
    Aqil A; Mehmood A; Moin M; Abid K
    J Pak Med Assoc; 2020 Oct; 70(10):1834-1837. PubMed ID: 33159763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Central serous chorioretinopathy--retinal function and morphology: microperimetry and optical coherence tomography].
    Springer C; Völcker HE; Rohrschneider K
    Ophthalmologe; 2006 Sep; 103(9):791-7. PubMed ID: 16874536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy.
    Jirarattanasopa P; Ooto S; Tsujikawa A; Yamashiro K; Hangai M; Hirata M; Matsumoto A; Yoshimura N
    Ophthalmology; 2012 Aug; 119(8):1666-78. PubMed ID: 22521082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic central serous chorioretinopathy: photodynamic therapy.
    Taban M; Boyer DS; Thomas EL; Taban M
    Am J Ophthalmol; 2004 Jun; 137(6):1073-80. PubMed ID: 15183792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of Anti-vascular Endothelial Growth Factor Treatment for Foveal Serous Retinal Detachment Associated with Inferior Staphyloma.
    Lee EK; Yu HG
    Korean J Ophthalmol; 2019 Jun; 33(3):228-237. PubMed ID: 31179654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SUBTHRESHOLD LASER TREATMENT FOR SEROUS RETINAL DETACHMENT IN DOME-SHAPED MACULA ASSOCIATED WITH PATHOLOGIC MYOPIA.
    Battaglia Parodi M; Iacono P; Bandello F
    Retina; 2018 Feb; 38(2):359-363. PubMed ID: 28145971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial.
    Chan WM; Lai TY; Lai RY; Liu DT; Lam DS
    Ophthalmology; 2008 Oct; 115(10):1756-65. PubMed ID: 18538401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photodynamic therapy for chronic central serous chorioretinopathy.
    Cardillo Piccolino F; Eandi CM; Ventre L; Rigault de la Longrais RC; Grignolo FM
    Retina; 2003 Dec; 23(6):752-63. PubMed ID: 14707823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subretinal dot-like precipitates and yellow material in central serous chorioretinopathy.
    Maruko I; Iida T; Ojima A; Sekiryu T
    Retina; 2011 Apr; 31(4):759-65. PubMed ID: 21052035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Foveal thickness can predict visual outcome in patients with persistent central serous chorioretinopathy.
    Furuta M; Iida T; Kishi S
    Ophthalmologica; 2009; 223(1):28-31. PubMed ID: 18849634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: Predisposing Factors for Visual Acuity Outcomes.
    Matušková V; Vysloužilová D; Uher M
    Semin Ophthalmol; 2018; 33(5):690-699. PubMed ID: 29252091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The expanded spectrum of focal choroidal excavation.
    Margolis R; Mukkamala SK; Jampol LM; Spaide RF; Ober MD; Sorenson JA; Gentile RC; Miller JA; Sherman J; Freund KB
    Arch Ophthalmol; 2011 Oct; 129(10):1320-5. PubMed ID: 21670327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FUNDUS AUTOFLUORESCENCE LIFETIMES AND CENTRAL SEROUS CHORIORETINOPATHY.
    Dysli C; Berger L; Wolf S; Zinkernagel MS
    Retina; 2017 Nov; 37(11):2151-2161. PubMed ID: 28099314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Features of central serous chorioretinopathy presenting at a tertiary care hospital in Lahore.
    Jamil AZ; Mirza KA; Qazi ZU; Iqbal W; Khaliq J; Fawad-ur-Rahman ; Ahmed A
    J Pak Med Assoc; 2013 Apr; 63(4):478-82. PubMed ID: 23905445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A long-term follow-up study of severe variant of central serous chorioretinopathy.
    Otsuka S; Ohba N; Nakao K
    Retina; 2002 Feb; 22(1):25-32. PubMed ID: 11884874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optical coherence tomography characterisation of idiopathic central serous chorioretinopathy.
    Montero JA; Ruiz-Moreno JM
    Br J Ophthalmol; 2005 May; 89(5):562-4. PubMed ID: 15834085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macular ganglion cell complex thickness in acute and chronic central serous chorioretinopathy.
    Demirok G; Kocamaz F; Topalak Y; Altay Y; Sengun A
    Int Ophthalmol; 2017 Apr; 37(2):409-416. PubMed ID: 27324370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spectral-domain optical coherence tomography imaging of the detached macula in rhegmatogenous retinal detachment.
    Nakanishi H; Hangai M; Unoki N; Sakamoto A; Tsujikawa A; Kita M; Yoshimura N
    Retina; 2009 Feb; 29(2):232-42. PubMed ID: 18997641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphologic features of large choroidal vessel layer: age-related macular degeneration, polypoidal choroidal vasculopathy, and central serous chorioretinopathy.
    Baek J; Lee JH; Jung BJ; Kook L; Lee WK
    Graefes Arch Clin Exp Ophthalmol; 2018 Dec; 256(12):2309-2317. PubMed ID: 30259090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.